| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$829 |
FG1:Flynn Reinforces Tasmanian Focus with Sale of WA Project
|
25 Feb 2026 8:48AM |
$0.565 |
$0.640 |
risen by
13.27%
|
|
FRS - Price-sensitive ASX Announcement
Full Release
Key Points
- Flynn Gold Limited has agreed to sell its Forrestania and Lake Johnston Projects in Western Australia to Forrestania Resources Limited.
- The sale is valued at $350,000 paid in the form of fully-paid ordinary shares of Forrestania Resources.
- This transaction is part of Flynn's strategy to divest non-core assets in Western Australia and focus on Tasmanian projects.
- Completion of the sale is anticipated by 31 March 2026, subject to due diligence and necessary regulatory and third-party approvals.
- Flynn Gold is shifting its focus to its Tasmanian gold, silver, and critical mineral projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Anagenics - 1H FY26 Result Highlights
|
25 Feb 2026 8:48AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
AN1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Anagenics reported a maiden profit of $127k in 1H FY26, reversing a $464k loss from 1H FY25.
- Revenue retention of 90% and gross profit margin improvement by 280bps.
- Operating expenses reduced by 44% following restructuring.
- Operating cash outflow significantly reduced to $0.6m from $1.2m.
- Annualized cost savings of $2.5m achieved via business unit disposals.
- Exited an office lease at Clarence Street, saving an additional $100k.
- Successfully completed a $2.25m equity raise for brand expansion.
- Agreement with York Street Brands generated $500k in royalties.
- Focused on long-term profitability for strategic partners and shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Anagenics - 1H26 HY Report DEC 2025
|
25 Feb 2026 8:47AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Appendix 4D 1H FY26 DEC 2025
|
25 Feb 2026 8:47AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
AN1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Anagenics reported a maiden profit of $126,685 for the half year ended 31 December 2025.
- Revenue and other income decreased by 10% to $2,635,660 compared to the previous period.
- Gross profit margin improved by 280 basis points.
- Operating expenses were reduced by 44%.
- No dividends were declared during the period.
- The financial statements were reviewed by Connect National Audit Pty Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wiseway Group Limited (WWG) ORDINARY FULLY PAID |
Industrials |
$48 |
1H26 Results Presentation
|
25 Feb 2026 8:47AM |
$0.320 |
$0.280 |
fallen by
12.50%
|
|
WWG - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue increased by 20% to $100.3 million.
- EBITDA grew by 21% to $7.2 million.
- Wiseway has re-organized into Wiseway Global Forwarding and Wiseway eCommerce Solutions.
- Overseas divisions are growing primarily driven by eCommerce.
- Healthy balance sheet with $14.4 million in cash.
- Focus on improving long-term capital structure and reducing debt.
- Continued investment in technology for supply chain visibility.
- Outlook for FY26 reflects sustained growth momentum.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wiseway Group Limited (WWG) ORDINARY FULLY PAID |
Industrials |
$48 |
1H26 Results Announcement
|
25 Feb 2026 8:46AM |
$0.320 |
$0.280 |
fallen by
12.50%
|
|
WWG - Price-sensitive ASX Announcement
Full Release
Key Points
- 20% increase in revenue to $100.3 million.
- EBITDA increased by 21% to $7.2 million.
- Net profit before tax rose by 78% to $2.8 million.
- Wiseway reorganized into Wiseway Global Forwarding and Wiseway eCommerce Solutions.
- Strong performance in Imports division and U.S. market.
- Regained 100% ownership of USA business.
- Partnership with Borderless360 to enhance technology-driven logistics.
- Continued focus on eCommerce and U.S. market for growth.
- Sustainable dividend distributions planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wiseway Group Limited (WWG) ORDINARY FULLY PAID |
Industrials |
$48 |
Appendix 4D and Half Year Report
|
25 Feb 2026 8:46AM |
$0.320 |
$0.280 |
fallen by
12.50%
|
|
WWG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to 100,279,000 AUD from 83,903,000 AUD.
- Net profit after tax was 2,211,000 AUD, up from 1,291,000 AUD.
- Exports and imports showed an increase in revenue.
- Total assets stood at 89,570,000 AUD as of 31 December 2025.
- The report includes detailed financial statements and notes.
- Cash flow from operations was positive despite investment and financing activities.
- Foreign currency translation reserves decreased.
- Continued investment in property, plant, and equipment.
- Proposed interim dividend of 1,033,000 AUD.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Growthpoint Properties Australia (GOZ) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,622 |
GOZ 1H26 Announcement
|
25 Feb 2026 8:45AM |
$2.200 |
$2.150 |
fallen by
2.27%
|
|
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$65 |
Notice of Extraordinary General Meeting/Proxy Form
|
25 Feb 2026 8:44AM |
$0.775 |
$0.650 |
fallen by
16.13%
|
|
| IVE Group Limited (IGL) ORDINARY FULLY PAID |
Communication Services |
$406 |
Dividend/Distribution - IGL
|
25 Feb 2026 8:44AM |
$2.970 |
$2.640 |
fallen by
11.11%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$46 |
Proposed issue of securities - RHY
|
25 Feb 2026 8:44AM |
$0.205 |
$0.130 |
fallen by
36.59%
|
|
| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$340 |
Director Appointment
|
25 Feb 2026 8:44AM |
$0.830 |
$0.565 |
fallen by
31.93%
|
|
| IVE Group Limited (IGL) ORDINARY FULLY PAID |
Communication Services |
$406 |
Appendix 4D and Half Year Results to 31 December 2025
|
25 Feb 2026 8:44AM |
$2.970 |
$2.640 |
fallen by
11.11%
|
|
IGL - Price-sensitive ASX Announcement
Full Release
Key Points
- IVE Group Limited's revenue decreased by 6.1% to $479.1 million.
- Net profit after tax (NPAT) fell by 10.2% to $24.3 million.
- Strategic acquisitions include Impressu, Budget Mail Services, and Daily Press.
- Impressu expected to contribute $30 million in annual revenue.
- Daily Press to enhance creative and content capabilities.
- Company maintained margin expansion due to cost control.
- Dividend of 9.5 cents per share declared.
- Expansion of 3PL capabilities with new sites.
- Preparation for climate-related financial disclosures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$46 |
Exercise of RHYO Options underwritten for $4.5m to $6.0m
|
25 Feb 2026 8:43AM |
$0.205 |
$0.130 |
fallen by
36.59%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Underwriting agreement with CPS Capital Group Pty Ltd for RHYO options.
- Provides $4.5 million to $6.0 million funding support.
- Options exercisable at $0.20, expiring 31 March 2026.
- Enhances funding for ColoSTAT® and geneType™ platforms.
- Potential issuance of up to 30,000,000 shares.
- Underwriting agreement not with a related party.
- Includes customary termination events and fees.
- Shares issued under ASX Listing Rule 7.2 Exception 10.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$25 |
Appendix 4D and Interim Financial Report
|
25 Feb 2026 8:43AM |
$0.355 |
$0.150 |
fallen by
57.75%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues decreased by 10% to $868,749 compared to the previous period.
- Loss after tax for members increased by 34% to $6,026,951.
- Controlled market launches of Promarker®D and Promarker®Eso in Australia.
- US reimbursement pricing established for Promarker®D, effective January 2026.
- Strengthened global intellectual property with a new US patent for Promarker®Eso.
- Focus on expanding market presence and commercial scale, particularly in the US.
- Strategic priorities include growing clinician adoption and innovating diagnostic solutions.
- Company aims to convert clinical validation into commercial expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,696 |
FY25 Results Presentation
|
25 Feb 2026 8:43AM |
$5.100 |
$4.460 |
fallen by
12.55%
|
|
| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$340 |
FY26 Half Year Results Investor Presentation
|
25 Feb 2026 8:43AM |
$0.830 |
$0.565 |
fallen by
31.93%
|
|
AX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Total sales increased by 5.7% to $810.5 million.
- Gross margin impacted by promotional environment and currency rates.
- Closure of OzSale and Glue businesses impacted results by $16.2 million.
- Net profit after tax decreased by 40.5% to $28.1 million.
- Interim dividend declared at 3.25 cents per share.
- 27 new stores opened in H1 FY26.
- Strategic partnership with Frasers Group for Sports Direct brand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alkane Resources Ltd (ALK) ORDINARY FULLY PAID |
Materials |
$2,005 |
Costerfield's Kendal Deposit Hits High-Grade Antimony-Gold
|
25 Feb 2026 8:42AM |
$1.685 |
$1.468 |
fallen by
12.91%
|
|
ALK - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade antimony-gold intercepts at Costerfield's Kendal Deposit.
- Significant drilling results with high gold and antimony grades.
- Methodology for gold-equivalent grade calculation.
- Drilling enhances resource estimates for future production potential.
- Part of Alkane Resources' strategic exploration and development plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aureka Limited (AKA) ORDINARY FULLY PAID |
Materials |
$13 |
Newly Identified High Grade Silver Component to St Arnaud
|
25 Feb 2026 8:42AM |
$0.115 |
$0.085 |
fallen by
26.09%
|
|
AKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Aureka Limited announces high-grade gold and silver findings at St Arnaud Comstock.
- Significant silver mineralisation identified along the strike.
- Diamond hole 25NED004 recorded 0.3m at 650g/t silver and 1.91g/t gold.
- Potential for economic high-grade gold and silver from new structures.
- Part of a 2025 diamond drilling program supporting further exploration and resource growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hazer Group Limited (HZR) ORDINARY FULLY PAID |
Materials |
$95 |
Hazer Releases FY26 Half Year Results
|
25 Feb 2026 8:41AM |
$0.390 |
$0.355 |
fallen by
8.97%
|
|
HZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Hazer Group released its FY26 Half Year Results ending 31 December 2025.
- The company reported a strong start to FY26, with key operational and financial achievements.
- Key corporate highlights include a global marketing and licensing campaign with KBR and a joint project with the UK Government-backed EnergyPathways.
- The company secured a partnership with POSCO and advanced its graphite market development.
- Financial highlights include a $17.2 million funding position, $1.5 million in revenue, and a reduction in operating costs by 27%.
- Hazer is focused on converting its project pipeline into license agreements and advancing its hydrogen and graphite projects.
- The Process Design Package (PDP) is on track for early 2026 completion to support commercial scale-up.
- The FY26 outlook includes converting pipelines to license agreements, advancing projects to Final Investment Decision, and monetizing Hazer’s graphite.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hazer Group Limited (HZR) ORDINARY FULLY PAID |
Materials |
$95 |
Half Yearly Report and Accounts
|
25 Feb 2026 8:41AM |
$0.390 |
$0.355 |
fallen by
8.97%
|
|
HZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Hazer Group Limited reported a total comprehensive loss of $5,045,120 for the half-year ended 31 December 2025.
- Revenue decreased by 37% to $1,471,060 compared to the previous period.
- There were no dividends paid, recommended, or declared during the financial period.
- The company entered a Project Development Agreement with FortisBC for a hydrogen production facility using Hazer's technology.
- The financial statements are prepared on a going concern basis.
- Cash and cash equivalents increased to $14,837,670 from $12,534,265 as at 30 June 2025.
- Trade and other receivables decreased significantly from $4,585,248 to $1,410,980.
- Hazer Group acquired Hazer Graphite Pte. Ltd. on 7th November 2025.
- No events after the reporting period have significantly affected the company's operations or financial state.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$323 |
Appendix 4G & Corporate Governance Statement
|
25 Feb 2026 8:41AM |
$1.325 |
$1.205 |
fallen by
9.06%
|
|
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$237 |
Half Year Results - Record Production and Earnings
|
25 Feb 2026 8:40AM |
$0.420 |
$0.310 |
fallen by
26.19%
|
|
FEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Record iron ore shipments of 2.1 million tonnes, a 126% increase.
- EBITDA of A$48.6 million, up 137%.
- NPAT of A$9.7 million, up 419%.
- Operating cash flow increased to A$56.0 million.
- Cash reserves grew to A$78.6 million.
- 30-year Right to Mine Agreement secured with Baowu.
- Growth strategy targets 6 Mtpa by FY28 and 10 Mtpa by 2031.
- C1 cash costs projected at $70-$80 per wet metric tonne.
- Weld Range Project scoping study outlines expansion strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$323 |
Investor Presentation
|
25 Feb 2026 8:40AM |
$1.325 |
$1.205 |
fallen by
9.06%
|
|
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$323 |
FY25 Results and FY26 Outlook
|
25 Feb 2026 8:39AM |
$1.325 |
$1.205 |
fallen by
9.06%
|
|
APX - Price-sensitive ASX Announcement
Full Release
Key Points
- Appen Limited's FY25 revenue totaled $230.8 million, up 4.5% compared to FY24.
- Gross margin improved by 100 basis points to 40.3% due to an increased mix of generative AI projects.
- Underlying EBITDA before FX was reported at $12.2 million, a 251% increase from FY24.
- Appen Global reported a revenue of $127.9 million for FY25, down 21% from the previous year.
- Appen China achieved a revenue of $102.9 million in FY25, up 75% from FY24.
- Strong performance in Q4 with Appen Global seeing a 56% revenue growth quarter-on-quarter.
- Appen China reported a record profit performance in Q4 with a 13.5% quarterly EBITDA margin.
- FY26 guidance includes expected revenue of $270 to $300 million and an underlying EBITDA margin of 5-10%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
